|
NYNRIN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87049999828193E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.23460000018328E-07 |
| Normal-vs-Stage2 |
4.52230000003162E-06 |
| Normal-vs-Stage3 |
4.541500E-03 |
| Normal-vs-Stage4 |
1.95329999996829E-06 |
| Stage1-vs-Stage2 |
6.538800E-01 |
| Stage1-vs-Stage3 |
4.240400E-01 |
| Stage1-vs-Stage4 |
1.923400E-01 |
| Stage2-vs-Stage3 |
3.518600E-01 |
| Stage2-vs-Stage4 |
4.493400E-01 |
| Stage3-vs-Stage4 |
1.413970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49969999999156E-06 |
| Normal-vs-AfricanAmerican |
9.14000000018511E-07 |
| Normal-vs-Asian |
1.290200E-02 |
| Caucasian-vs-AfricanAmerican |
1.768590E-01 |
| Caucasian-vs-Asian |
6.653800E-01 |
| AfricanAmerican-vs-Asian |
8.821600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36350000001784E-06 |
| Normal-vs-Female |
9.594500E-04 |
| Male-vs-Female |
1.847220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.50509999996551E-06 |
| Normal-vs-Extreme_Weight |
2.7837000005082E-07 |
| Normal-vs-Obese |
1.42390000013037E-07 |
| Normal-vs-Extreme_Obese |
1.121460E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.081000E-01 |
| Normal_Weight-vs-Obese |
6.767600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.096200E-01 |
| Extreme_Weight-vs-Obese |
2.572600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.143400E-01 |
| Obese-vs-Extreme_Obese |
6.575400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.827700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.8428999999951E-06 |
| Normal-vs-Age(61-80Yrs) |
4.38449999999868E-05 |
| Normal-vs-Age(81-100Yrs) |
1.43580000000476E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.138600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.936200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.323200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.740200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.553900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.800400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.03310000004942E-06 |
| Normal-VS-Type2 PRCC |
1.45559997388744E-09 |
| Normal-VS-KIRP CIMP |
1.43580003442167E-09 |
| Normal-VS-Unclassified PRCC |
1.200960E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.264200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.24280047259151E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
2.186400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.802500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.094100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.12690000000504E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96350000492407E-08 |
| Normal-vs-N1 |
6.830500E-04 |
| Normal-vs-N2 |
4.304400E-02 |
| N0-vs-N1 |
3.344800E-01 |
| N0-vs-N2 |
5.430400E-01 |
| N1-vs-N2 |
8.884000E-01 |
|
|
